Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Vividrin Hayfever 2 % w/v Eye Drops, solution

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Sodium cromoglicate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Sodium cromoglicate

Equivalent medicines (same active substance, strength and form)

and 13 more with the same active substance, strength and form

Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

for Vividrin contains the active substance sodium cromoglicate. This belongs to a group of medicines called anti-allergics. Vividrin is used for the relief and treatment of the eye symptoms of hayfever (which is an allergic condition) such as red, sore, itchy and watery eyes. You must talk to a doctor if you do not feel better or if you feel worse.

What you need to know before you take it

e Vividrin Do not use these drops — If you are allergic (hypersensitive) to sodium cromoglicate or any of the other ingredients of this medicine including benzalkonium chloride (listed in section 6). Warnings and precautions — Do not use if the bottle has been opened before you are given it. — Throw the bottle away 1 month after first opening it or if the solution stops looking clear. Other medicines and Vividrin — Tell your pharmacist if you are using, have recently used or might use any other medicines. Pregnancy and breastfeeding — If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Driving and using machines — Vividrin can cause stinging and blurring of vision when first used. Do not drive or operate machinery until proper vision is restored. Vividrin contains benzalkonium chloride This medicine contains 0.00306 mg benzalkonium chloride in each drop (0.0306ml) which is equivalent to 0.1 mg/1 ml. Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.

Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor. Vividrin contains Polysorbate Vividrin contains polysorbate which can cause allergic reactions.

How to take it

Vividrin Always use this medicine exactly as described in this leaflet or as your pharmacist has told you. Check with your pharmacist if you are not sure. If your eyes are no better after 2 days of using the eye drops, see your doctor or pharmacist. If you find you need to use the drops continuously for more than 14 days, then check with your pharmacist or doctor before continuing. Dosage Unless otherwise prescribed, the dose for adults and children over 6 years is 1 or 2 drops into each eye 4 times daily. Apply your eye drops in the following way: 1. Before using your Vividrin Hayfever Eye Drops you should wash your hands. 2. You may find it helps to sit in front of a mirror, so that you can see what you are doing. Tilt your head backwards, gently pull down your lower eyelid and carefully place one or two Vividrin Hayfever Eye Drops in the space between the eyelid and the eye. Take care not to touch the dropper with your eye or fingers. 3. Release the eyelid and blink a few times to make sure the liquid covers the whole surface of the eye. 4. Repeat the procedure with the other eye and then replace the cap on the bottle. If you use more Vividrin than you should If you use more Vividrin than you should contact your doctor or pharmacist. If you forget to use Vividrin Use your drops as soon as you remember and then carry on in the usual way. Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. If you experience any difficulty stop using your drops and talk to your doctor or pharmacist. The following

Possible side effects

may occur:

  • Like with all eye drops, you may have a brief blurring of vision or a slight stinging feeling after using the drops.
  • Irritation or itching of the eye may occur in a very small number of people. Talk to your doctor or pharmacist if any of the side effects become serious or last longer than a few days, or if you notice any side effects not listed in this leaflet. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via: United Kingdom Yellow Card Scheme

Website: www.mhra.gov.uk/ yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

How to store it

Vividrin Keep this medicine out of the sight and reach of children. — Do not use this medicine after the expiry date which is stated on the carton and label. The expiry date refers to the last day of that month. — Do not use the eye drops more than four weeks after first opening the bottle. Discard any unused medicine after this time. — Do not use this medicine if you notice the solution is cloudy. Store below 25oC. Keep bottle in outer carton to protect from light. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Contents of the pack and other information

What Vividrin contains — The active substance is Sodium Cromoglicate. — The other ingredients are Benzalkonium Chloride, Edetic Acid Disodium Salt, Polysorbate, Sorbitol, Sodium Hydroxide and Purified Water. What Vividrin looks like and contents of the pack Your eye drops are sterile preserved multidose eye drops and are supplied in plastic bottles. Each bottle has a volume of 10.0 ml. The eye drops are a clear solution.

Marketing Authorisation Holder and Manufacturer The Marketing Authorisation Holder is: Bausch & Lomb UK Limited 106 London Road Kingston-Upon-Thames Surrey, United Kingdom KT2 6TN The Manufacturer is: Dr. Gerhard Mann Chem-pharm. Fabrik GmbH Brunsbütteler Damm 165/173 13581 Berlin Germany This leaflet was last revised: August 2024.

Frequently asked questions about Vividrin Hayfever 2 % w/v Eye Drops, solution

How do I take Vividrin Hayfever 2 % w/v Eye Drops, solution?

Vividrin Hayfever 2 % w/v Eye Drops, solution comes as eye drops. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Vividrin Hayfever 2 % w/v Eye Drops, solution?

The active substance in Vividrin Hayfever 2 % w/v Eye Drops, solution is sodium cromoglicate.

Are there equivalent medicines to Vividrin Hayfever 2 % w/v Eye Drops, solution?

Medicines with the same active substance, strength and form include: Allercrom 2% w/v Eye Drops, Allergy Relief 2% w/v eye drops, Solution, Aspire Hayfever Relief 2% w/v Eye Drops, solution. In total there are 18 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Vividrin Hayfever 2 % w/v Eye Drops, solution, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Vividrin Hayfever 2 % w/v Eye Drops, solution without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Sodium cromoglicate (21 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

For the relief and treatment of the eye symptoms of hayfever.

4.2. Posology and method of administration

Method of Administration:

For topical administration to the eye.

Adults, Elderly and Children over 6 years

One or two drops into each eye four times daily.

Vividrin Hayfever Eye Drops should not be used continuously for more than 14 days except on the advice of a doctor or pharmacist.

4.3. Contraindications

Hypersensitivity to the active substance sodium cromoglicate or to any of the excipients listed in section 6.1.

4.4. Special warnings and precautions for use

The solution should be discarded 1 month after first opening the bottle or if any turbidity develops. Do not use if the bottle has been opened prior to receipt.

Vividrin Hayfever Eye Drops contains benzalkonium chloride

This medicinal product contains 0.00306 mg benzalkonium chloride in each drop (0.0306ml) which is equivalent to 0.1 mg/ml.

Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. Patients should remove contact lenses before using this medicine and put them back 15minutes afterwards.

Benzalkonium chloride has been reported to cause eye irritation, symptoms of dry eyes and may affect the tear film and corneal surface. Vividrin Hayfever Eye Drops should be used with caution in dry eye patients and in patients where the cornea may be compromised.

Patients should be monitored in case of prolonged use.

Vividrin contains Polysorbate

Vividrin contains polysorbate which can cause allergic reactions.

The carton label and patient information leaflet will state:

• The patient should consult a doctor or pharmacist if symptoms do not start to improve within 48 hours,

• Vividrin Hayfever Eye Drops should not be used continuously for more than 14 days except on the advice of a doctor or pharmacist.

4.5. Interaction with other medicinal products and other forms of interaction

None known.

4.6. Fertility, pregnancy and lactation

Pregnancy

Vividrin Hayfever Eye Drops should be used cautiously during pregnancy and lactation. The widespread use of sodium cromoglicate has yet to reveal any adverse effects to mother or child during pregnancy.

Lactation

It is not known whether sodium cromoglicate is excreted in human breast milk but on the basis of its physicochemical properties, this is considered unlikely. There is no information to suggest that the use of sodium cromoglicate has any undesirable effects on the baby.

4.7. Effects on ability to drive and use machines

Transient stinging or blurred vision may occur on instillation. Do not drive or operate machinery until proper vision is restored.

4.8. Undesirable effects

Transient stinging and blurring may occur after instillation, other symptoms of local irritation have been reported rarely.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:

United Kingdom

Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

As sodium cromoglicate is absorbed only to a very limited extent from eye drops, no action other than medical observation should be necessary. In the event of accidental ingestion, symptomatic treatment is recommended.

💬 Ask about this leaflet

Ask anything about Vividrin Hayfever 2 % w/v Eye Drops, solution. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →